Plain-English translation of NCT02206841 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study designed to build a large database of patients with non-alcoholic fatty liver disease (NAFLD)—a common condition where fat builds up in the liver. The researchers will collect blood samples, perform imaging tests, and analyze liver tissue to develop better ways to predict which patients will develop serious liver scarring (fibrosis) over time.
Currently, doctors lack reliable tools to identify which patients with fatty liver disease will progress to severe liver damage. This study aims to discover new biological markers and patterns that can help predict who is at highest risk, so doctors can intervene earlier and prevent serious complications.
You likely qualify if…
You likely don't qualify if…
If you enroll, you would visit the research center for baseline testing, which includes blood draws, liver imaging (ultrasound and CT scans), heart and lung function tests, brain imaging, and possibly a liver biopsy to confirm the extent of fat and scarring. Your blood samples and any tissue collected would be stored and analyzed using advanced genetic and molecular techniques. The study is still recruiting participants, so timing and follow-up visits would be discussed with the research team.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
South Korea
Sponsor
Seoul National University Boramae Hospital
Enrollment target
~1,000 participants
Started
January 2014
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Won Kim, MD,PhD
SMG-SNU Boramae Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.